Circadian modulation of GABA-mediated cortical inhibition

Cerebral Cortex

Volumn 21, Issue 10, 2011, Pages 2299-2306

  Lang, Nicolas ^a,b   Rothkegel, Holger ^a,b   Reiber, Heidi ^b   Hasan, Alkomiet ^b,c   Sueske, Elke ^b   Tergau, Frithjof ^b   Ehrenreich, Hannelore ^d   Wuttke, Wolfgang ^c   Paulus, Walter ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b Department of Clinical Neurophysiology ^*  (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Circadian rhythm; Cortical silent period; Dexamethasone suppression test; Motor cortex excitability; Transcranial magnetic stimulation

Indexed keywords

4 AMINOBUTYRIC ACID; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; CIRCADIAN RHYTHM; CONTROLLED STUDY; FACILITATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PYRAMIDAL TRACT; SLEEP DEPRIVATION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; CIRCADIAN RHYTHM; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MOTOR CORTEX; NEURAL INHIBITION; POLYSOMNOGRAPHY; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 80052682830     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhr003     Document Type: Article

References (56)

1. American Academy of Sleep Medicine. 2005. ICSD-2 International classification of sleep disorders, 2nd ed. Diagnostic and coding manual. Westchester (IL): American Academy of Sleep Medicine.
2. Abbruzzese G, Trompetto C. 2002. Clinical and research methods for evaluating cortical excitability. J Clin Neurophysiol. 19:307-321. (Pubitemid 35304366)
3. Adrien J. 2002. Neurobiological bases for the relation between sleep and depression. Sleep Med Rev. 6:341-351. (Pubitemid 36529358)
4. Bale TL, ValeWW. 2004. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 44:525-557. (Pubitemid 38263852)
5. Boroojerdi B, Battaglia F, Muellenbacher W, Cohen L. 1999. Evaluation of the effects of CNS-active drugs on cortical excitability in intact humans. Neurology. 52:A457.
6. Calogero AE, Gallucci WT, Chrousos GP, Gold PW. 1988. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin- releasing hormone secretion in vitro. Brain Res. 463:28-36.
7. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, et al. 1981. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry. 38:15-22. (Pubitemid 11156708)
8. Chen R. 2000. Studies of human motor physiology with transcranial magnetic stimulation. Muscle Nerve Suppl. 9:S26-S32.
9. Chen R, Lozano AM, Ashby P. 1999. Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings. Exp Brain Res. 128:539-542. (Pubitemid 29469179)
10. Chen R, Samii A, Canos M, Wassermann EM, Hallett M. 1997. Effects of phenytoin on cortical excitability in humans. Neurology. 49:881-883. (Pubitemid 27428043)
11. Connors BW, Malenka RC, Silva LR. 1988. Two inhibitory postsynaptic potentials, and GABAA and GABAB receptor-mediated responses in neocortex of rat and cat. J Physiol. 406:443-468.
12. Cullinan WE, Ziegler DR, Herman JP. 2008. Functional role of local GABAergic influences on the HPA axis. Brain Struct Funct. 213:63-72.
13. Dautzenberg FM, Hauger RL. 2002. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci. 23:71-77. (Pubitemid 34119328)
14. Davies CH, Starkey SJ, Pozza MF, Collingridge GL. 1991. GABA autoreceptors regulate the induction of LTP. Nature. 349:609-611. (Pubitemid 21912114)
15. Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Pilato F, Zito G, Dileone M, Nicoletti R, Pasqualetti P, Tonali PA. 2003. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. J Physiol. 547:485-496. (Pubitemid 36304982)
16. Di Lazzaro V, Oliviero A, Profice P, Saturno E, Pilato F, Insola A, Mazzone P, Tonali P, Rothwell JC. 1998. Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. Electroencephalogr Clin Neurophysiol. 109:397-401.
17. Doeltgen SH, Ridding MC. 2010. Behavioural exposure and sleep do not modify corticospinal and intracortical excitability in the human motor system. Clin Neurophysiol. 121:448-452.
18. Dunn AJ, Berridge CW. 1990. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. 15:71-100.
19. Fuhr P, Agostino R, Hallett M. 1991. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol. 81:257-262.
20. Gao SF, Bao AM. 2010. Corticotropin-releasing hormone, glutamate and c-aminobutyric acid in depression. Neuroscientist. doi: 10.1177/ 1073858410361780.
21. Griefahn B. 2002. Einsatz eines Fragebogens (DMEQ) zur Bestimmung des Chronotyps bei der Zuweisung eines Schichtarbeitsplatzes. Z Arb Wiss. 56:3.
22. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. 2003. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropinreleasing factor and their ligands. Pharmacol Rev. 55:21-26. (Pubitemid 36268397)
23. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM. 2006. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets. 5:453-479. (Pubitemid 44203356)
24. Heinrichs SC,De Souza EB. 1999.Corticotropin-releasing factor antagonists, binding-protein and receptors: implications for central nervous system disorders. Baillieres Best Pract Res Clin Endocrinol Metab. 13:541-554. (Pubitemid 30315884)
25. Holsboer F, BenderW, Benkert O, Klein HE, SchmaussM. 1980. Diagnostic value of dexamethasone suppression test in depression. Lancet. 2:706. (Pubitemid 10048676)
26. Inghilleri M, Berardelli A, Cruccu G, Manfredi M. 1993. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol. 466:521-534. (Pubitemid 23225241)
27. Koski L, Schrader LM, Wu AD, Stern JM. 2005. Normative data on changes in transcranial magnetic stimulation measures over a ten hour period. Clin Neurophysiol. 116:2099-2109. (Pubitemid 41262202)
28. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD. 1993. Corticocortical inhibition in human motor cortex. J Physiol. 471:501-519. (Pubitemid 23345592)
29. Lang N, Sueske E, Hasan A, Paulus W, Tergau F. 2006. Pregabalin exerts oppositional effects on different inhibitory circuits in human motor cortex: a double-blind, placebo-controlled transcranial magnetic stimulation study. Epilepsia. 47:813-819. (Pubitemid 44030175)
30. Liepert J, Schwenkreis P, Tegenthoff M, Malin JP. 1997. The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm. 104:1207-1214. (Pubitemid 28031814)
31. Martins JM, Kastin AJ, Banks WA. 1996. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology. 63:338-348. (Pubitemid 26117200)
32. McDonnell MN, Orekhov Y, Ziemann U. 2006. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp Brain Res. 173:86-93. (Pubitemid 44099702)
33. Millan MA, Jacobowitz DM, Hauger RL, Catt KJ, Aguilera G. 1986. Distribution of corticotropin-releasing factor receptors in primate brain. Proc Natl Acad Sci U S A. 83:1921-1925. (Pubitemid 16018675)
34. Mohammadi B, Krampfl K, Petri S, Bogdanova D, Kossev A, Bufler J, Dengler R. 2006. Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve. 33:778-784. (Pubitemid 43856795)
35. Mott DD, Lewis DV, Ferrari CM, Wilson WA, Swartzwelder HS. 1990. Baclofen facilitates the development of long-term potentiation in the rat dentate gyrus. Neurosci Lett. 113:222-226. (Pubitemid 20180689)
36. Nakamura H, Kitagawa H, Kawaguchi Y, Tsuji H. 1997. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol. 498(Pt 3):817-823. (Pubitemid 27089476)
37. Oldfield RC. 1971. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 9:97-113.
38. Olpe HR, Karlsson G. 1990. The effects of baclofen and two GABABreceptor antagonists on long-term potentiation. Naunyn Schmiedebergs Arch Pharmacol. 342:194-197. (Pubitemid 20258839)
39. Olpe HR, Worner W, Ferrat T. 1993. Stimulation parameters determine role of GABAB receptors in long-term potentiation. Experientia. 49:542-546. (Pubitemid 23257979)
40. Paulus W, Trenkwalder C. 2006. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol. 5:878-886. (Pubitemid 44715823)
41. Pfutze M, Reis J, Haag A, John D, Hattemer K, Oertel WH, Rosenow F, Hamer HM. 2007. Lack of differences of motorcortical excitability in the morning as compared to the evening in juvenile myoclonic epilepsy-a study using transcranial magnetic stimulation. Epilepsy Res. 74:239-242. (Pubitemid 46654753)
42. Pung T, Schmitz B. 2006. Circadian rhythm and personality profile in juvenile myoclonic epilepsy. Epilepsia. 47(2 Suppl):111-114. (Pubitemid 44684639)
43. Rothwell JC, Hallett M, Berardelli A, Eisen A, Rossini P, Paulus W. 1999. Magnetic stimulation: motor evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 52:97-103.
44. Sale MV, Ridding MC, Nordstrom MA. 2008. Cortisol inhibits neuroplasticity induction in humanmotor cortex. J Neurosci. 28:8285-8293.
45. Sanger TD, Garg RR, Chen R. 2001. Interactions between two different inhibitory systems in the humanmotor cortex. J Physiol. 530:307-317. (Pubitemid 32998879)
46. Siebner HR, Dressnandt J, Auer C, Conrad B. 1998. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve. 21:1209-1212. (Pubitemid 28355572)
47. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM. 2002. Effects of ovarian hormones on human cortical excitability. Ann Neurol. 51:599-603.
48. Smith MJ, Keel JC, Greenberg BD, Adams LF, Schmidt PJ, Rubinow DA, Wassermann EM. 1999. Menstrual cycle effects on cortical excitability. Neurology. 53:2069-2072.
49. Staubli U, Scafidi J, Chun D. 1999. GABAB receptor antagonism: facilitatory effects on memory parallel those on LTP induced by TBS but not HFS. J Neurosci. 19:4609-4615. (Pubitemid 29241108)
50. Tamm AS, Lagerquist O, Ley AL, Collins DF. 2009. Chronotype influences diurnal variations in the excitability of the human motor cortex and the ability to generate torque during a maximum voluntary contraction. J Biol Rhythms. 24:211-224.
51. Vale W, Spiess J, Rivier C, Rivier J. 1981. Characterization of a 41- residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1394-1397. (Pubitemid 12243637)
52. Valls-Sole J, Pascual-Leone A, Wassermann EM, Hallett M. 1992. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol. 85:355-364. (Pubitemid 23011246)
53. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J. 1999. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol. 517(Pt 2):591-597. (Pubitemid 29296371)
54. Wynn PC, Hauger RL, Holmes MC, Millan MA, Catt KJ, Aguilera G. 1984. Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides. 5:1077-1084. (Pubitemid 15135934)
55. Ziemann U, Chen R, Cohen LG, Hallett M. 1998. Dextromethorphan decreases the excitability of the human motor cortex. Neurology. 51:1320-1324. (Pubitemid 28520551)
56. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. 1996. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 40:367-378. (Pubitemid 26304794)